MARKET

MBX

MBX

MBX Biosciences Inc
NASDAQ
37.67
+1.62
+4.49%
After Hours: 37.62 -0.05 -0.13% 19:19 02/06 EST
OPEN
36.77
PREV CLOSE
36.05
HIGH
38.12
LOW
36.63
VOLUME
345.36K
TURNOVER
--
52 WEEK HIGH
44.89
52 WEEK LOW
4.807
MARKET CAP
1.69B
P/E (TTM)
-11.1069
1D
5D
1M
3M
1Y
5Y
1D
MBX Biosciences Raises $87 Million in ATM Offering
TipRanks · 2d ago
Weekly Report: what happened at MBX last week (0126-0130)?
Weekly Report · 5d ago
A Look At MBX Biosciences (MBX) Valuation After New Barclays Overweight Coverage
Simply Wall St · 6d ago
How Investors Are Reacting To MBX Biosciences (MBX) Adding Veteran CFO Laurie Stelzer To Its Board
Simply Wall St · 01/31 07:18
Add Up The Parts: IHE Could Be Worth $96
NASDAQ · 01/29 12:07
MBX Biosciences Price Target Announced at $66.00/Share by Barclays
Dow Jones · 01/28 14:54
MBX Biosciences Initiated at Overweight by Barclays
Dow Jones · 01/28 14:54
Barclays Initiates Coverage On MBX Biosciences with Overweight Rating, Announces Price Target of $66
Benzinga · 01/28 14:45
More
About MBX
MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. It has built its proprietary Precision Endocrine Peptide platform to develop precision peptide therapies that are designed to overcome key limitations of current peptide therapies. Its product candidates and programs include MBX 2109, MBX 1416 and Obesity portfolio. MBX 2109 is a parathyroid hormone peptide prodrug that is designed as a potential long-acting hormone replacement therapy for the treatment of chronic hypoparathyroidism. MBX 1416 is designed to be a long-acting glucagon-like peptide-1 (GLP-1), receptor antagonist, as a potential therapy for post-bariatric hypoglycemia, a chronic complication of bariatric surgery. MBX 4291 is designed to be a long-acting and highly potent GLP-1 and glucose-dependent insulinotropic polypeptide, receptor co-agonist prodrug.

Webull offers MBX Biosciences, Inc. stock information, including NASDAQ: MBX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MBX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MBX stock methods without spending real money on the virtual paper trading platform.